Trial Outcomes & Findings for Nitrite Supplementation in Long COVID Patients (NCT NCT05618574)
NCT ID: NCT05618574
Last Updated: 2026-08-26
Results Overview
Rating of Rate of Perceived Exertion (RPE) during the 5th minute of a 5-min of a 1.5 mile per hour steady-state treadmill walking test is used as an assessment of fatigability. RPE scale is from 6 (no physical exertion) - 20 (maximal exertion/very hard). This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
COMPLETED
PHASE2
17 participants
Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeks
2026-08-26
Participant Flow
Participant milestones
| Measure |
Beet-It Nitrate Beverage
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Overall Study
STARTED
|
8
|
9
|
|
Overall Study
COMPLETED
|
6
|
9
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
| Measure |
Beet-It Nitrate Beverage
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
0
|
|
Overall Study
Lost to Follow-up
|
1
|
0
|
Baseline Characteristics
One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
Baseline characteristics by cohort
| Measure |
Beet-It Nitrate Beverage
n=8 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
Total
n=17 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
61.4 Years
STANDARD_DEVIATION 15.9 • n=8 Participants
|
61.2 Years
STANDARD_DEVIATION 14.3 • n=9 Participants
|
61.3 Years
STANDARD_DEVIATION 14.6 • n=17 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=8 Participants
|
8 Participants
n=9 Participants
|
15 Participants
n=17 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=8 Participants
|
2 Participants
n=9 Participants
|
3 Participants
n=17 Participants
|
|
Race (NIH/OMB)
White
|
7 Participants
n=8 Participants
|
6 Participants
n=9 Participants
|
13 Participants
n=17 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
8 Participants
n=8 Participants
|
9 Participants
n=9 Participants
|
17 Participants
n=17 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Education
Less than high school
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Education
Some high school
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Education
High school degree or GED
|
1 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Education
Partial college (at least one year) or specialized training
|
2 Participants
n=8 Participants
|
3 Participants
n=9 Participants
|
5 Participants
n=17 Participants
|
|
Education
College degree
|
4 Participants
n=8 Participants
|
2 Participants
n=9 Participants
|
6 Participants
n=17 Participants
|
|
Education
Graduate or professional degree (Masters or Doctorate)
|
1 Participants
n=8 Participants
|
4 Participants
n=9 Participants
|
5 Participants
n=17 Participants
|
|
Education
Other
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Employment Status
Full time
|
3 Participants
n=8 Participants
|
3 Participants
n=9 Participants
|
6 Participants
n=17 Participants
|
|
Employment Status
Regular part time
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Employment Status
Irregular part time
|
1 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Employment Status
Active duty military service
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Employment Status
Veteran disability
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Employment Status
Retired
|
4 Participants
n=8 Participants
|
3 Participants
n=9 Participants
|
7 Participants
n=17 Participants
|
|
Employment Status
Unemployed
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Employment Status
Other
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Marital Status
Married or permanent partnership
|
5 Participants
n=8 Participants
|
5 Participants
n=9 Participants
|
10 Participants
n=17 Participants
|
|
Marital Status
Widowed
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Marital Status
Divorced or separated
|
1 Participants
n=8 Participants
|
3 Participants
n=9 Participants
|
4 Participants
n=17 Participants
|
|
Marital Status
Never married
|
2 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
Marital Status
In a relationship
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
Marital Status
Other
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
Social Support
Lives alone
|
2 Participants
n=8 Participants
|
3 Participants
n=9 Participants
|
5 Participants
n=17 Participants
|
|
Social Support
Lives with others
|
6 Participants
n=8 Participants
|
6 Participants
n=9 Participants
|
12 Participants
n=17 Participants
|
|
COVID-19 Hospitalization
Yes
|
2 Participants
n=8 Participants
|
2 Participants
n=9 Participants
|
4 Participants
n=17 Participants
|
|
COVID-19 Hospitalization
No
|
5 Participants
n=8 Participants
|
6 Participants
n=9 Participants
|
11 Participants
n=17 Participants
|
|
COVID-19 Hospitalization
Not Applicable or Not Reported
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
COVID-19 Symptoms
Less than 2 weeks
|
1 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
COVID-19 Symptoms
2 weeks to less than 1 month
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
COVID-19 Symptoms
1 month to less than 2 months
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
COVID-19 Symptoms
2 months to less than 3 months
|
0 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
1 Participants
n=17 Participants
|
|
COVID-19 Symptoms
3 months to less than 4 months
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
COVID-19 Symptoms
4 months to less than 6 months
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
COVID-19 Symptoms
Greater than 6 months
|
4 Participants
n=8 Participants
|
5 Participants
n=9 Participants
|
9 Participants
n=17 Participants
|
|
COVID-19 Symptoms
Not Applicable or Not Reported
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
COVID-19 Vaccination
Yes
|
7 Participants
n=8 Participants
|
8 Participants
n=9 Participants
|
15 Participants
n=17 Participants
|
|
COVID-19 Vaccination
No
|
0 Participants
n=8 Participants
|
0 Participants
n=9 Participants
|
0 Participants
n=17 Participants
|
|
COVID-19 Vaccination
Not Applicable or Not Reported
|
1 Participants
n=8 Participants
|
1 Participants
n=9 Participants
|
2 Participants
n=17 Participants
|
|
Fatigability
|
7.1 Score on a scale
STANDARD_DEVIATION 1.3 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
9.3 Score on a scale
STANDARD_DEVIATION 2.3 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
8.4 Score on a scale
STANDARD_DEVIATION 2.2 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
Walking Efficiency
|
9.4 ml/kg/min
STANDARD_DEVIATION 1.3 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
9.3 ml/kg/min
STANDARD_DEVIATION 1.9 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
9.3 ml/kg/min
STANDARD_DEVIATION 1.6 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
Peak oxygen utilization (VO2) non-normalized (ml/min)
|
2125.7 ml/min
STANDARD_DEVIATION 894.3 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
1924.4 ml/min
STANDARD_DEVIATION 808.4 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
2012.5 ml/min
STANDARD_DEVIATION 824.1 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
Peak oxygen utilization (VO2) normalized to weight (mL/kg/min)
|
21.7 mL/kg/min
STANDARD_DEVIATION 6.4 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
21.0 mL/kg/min
STANDARD_DEVIATION 8.5 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
21.3 mL/kg/min
STANDARD_DEVIATION 7.5 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
VO2 at anaerobic threshold (AT) non-normalized (ml/min)
|
1782.7 ml/min
STANDARD_DEVIATION 835.3 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
1526.6 ml/min
STANDARD_DEVIATION 648.3 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
1638.6 ml/min
STANDARD_DEVIATION 721.4 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
VO2 at anaerobic threshold (AT) normalized to weight (ml/kg/min)
|
18.1 ml/kg/min
STANDARD_DEVIATION 6.3 • n=7 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
16.7 ml/kg/min
STANDARD_DEVIATION 6.5 • n=9 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
17.3 ml/kg/min
STANDARD_DEVIATION 6.2 • n=16 Participants • One participant in the Beet-It nitrate beverage group did not complete a baseline CPET test due to staff concerns about safety during the pre-test safety assessment.
|
|
400m Corridor Walk Test
|
5.7 minutes
STANDARD_DEVIATION 1.2 • n=8 Participants
|
7.1 minutes
STANDARD_DEVIATION 2.6 • n=9 Participants
|
6.5 minutes
STANDARD_DEVIATION 2.1 • n=17 Participants
|
|
Short Performance Physical Battery (SPPB)
|
10.5 Score on a scale
STANDARD_DEVIATION 1.8 • n=8 Participants
|
10.1 Score on a scale
STANDARD_DEVIATION 2.2 • n=9 Participants
|
10.3 Score on a scale
STANDARD_DEVIATION 2.0 • n=17 Participants
|
|
Mitochondrial Respiration
|
86.3 pmol/mg/min
STANDARD_DEVIATION 6.0 • n=2 Participants • Baseline muscle biopsies were completed for 2 participants in the Beet-It group, and 6 participants in the placebo group. The participants who have no respirometry data available refused completion of the biopsy.
|
76.5 pmol/mg/min
STANDARD_DEVIATION 15.0 • n=6 Participants • Baseline muscle biopsies were completed for 2 participants in the Beet-It group, and 6 participants in the placebo group. The participants who have no respirometry data available refused completion of the biopsy.
|
78.9 pmol/mg/min
STANDARD_DEVIATION 13.6 • n=8 Participants • Baseline muscle biopsies were completed for 2 participants in the Beet-It group, and 6 participants in the placebo group. The participants who have no respirometry data available refused completion of the biopsy.
|
|
Serum Nitrite
|
0.9 µmol/L
STANDARD_DEVIATION 0.1 • n=5 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
0.9 µmol/L
STANDARD_DEVIATION 0.6 • n=7 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
0.9 µmol/L
STANDARD_DEVIATION 0.4 • n=12 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
|
Serum Nitrate
|
19.9 µmol/L
STANDARD_DEVIATION 8.6 • n=5 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
17.1 µmol/L
STANDARD_DEVIATION 4.0 • n=7 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
18.3 µmol/L
STANDARD_DEVIATION 6.1 • n=12 Participants • Serological data were available for 5 participants in the Beet-It group and 7 participants in the placebo group. Those with missing data refused the blood draw.
|
|
Veterans RAND-12
Physical Component Score
|
37.5 T-score
STANDARD_DEVIATION 12.9 • n=8 Participants
|
36.5 T-score
STANDARD_DEVIATION 14.9 • n=9 Participants
|
37.0 T-score
STANDARD_DEVIATION 13.6 • n=17 Participants
|
|
Veterans RAND-12
Mental Component Score
|
52.5 T-score
STANDARD_DEVIATION 10.7 • n=8 Participants
|
55.8 T-score
STANDARD_DEVIATION 8.5 • n=9 Participants
|
54.2 T-score
STANDARD_DEVIATION 9.4 • n=17 Participants
|
PRIMARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 3 participants did not have follow-up CPET data for fatigability due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1).
Rating of Rate of Perceived Exertion (RPE) during the 5th minute of a 5-min of a 1.5 mile per hour steady-state treadmill walking test is used as an assessment of fatigability. RPE scale is from 6 (no physical exertion) - 20 (maximal exertion/very hard). This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Fatigability
|
0.2 Score on a scale
Standard Deviation 1.5
|
-0.7 Score on a scale
Standard Deviation 0.9
|
PRIMARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 4 participants did not have follow-up CPET data for walking efficiency due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1), missing data (n=1).
Walking efficiency (VO2/kg) is assessed by incorporating VO2 assessments during the 5-min steady-state walking protocol. This is assessed using cardiopulmonary exercise testing (CPET) equipment. A lower VO2 for the same functional workload indicates improved efficiency. This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=8 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Walking Efficiency
|
-0.7 ml/kg/min
Standard Deviation 1.4
|
-0.8 ml/kg/min
Standard Deviation 0.9
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 2 participants did not complete a follow-up 400m walk test due to participant withdrawal (n=1) and loss to follow-up/unable to reach to complete assessment (n=1).
This test measures the amount of time it takes the participant to walk a 400-meter course to assess cardiovascular and pulmonary fitness or to predict adverse outcomes such as mobility disability. his is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=6 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
400m Corridor Walk Test (400MCW)
|
0.8 minutes
Standard Deviation 2.4
|
-0.6 minutes
Standard Deviation 1.1
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 2 participants did not complete a follow-up SPPB due to participant withdrawal (n=1) and loss to follow-up/unable to reach to complete assessment (n=1).
The SPPB is a test of balance, gait, strength, and endurance that combines gait speed, chair stand and balance tests. SPPB scaled score ranges from 0 - 12. Scores of 0 indicate that the participant is unable/barely able to perform the tasks, while 12 indicates they completed all tasks optimally. This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=6 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Short Performance Physical Battery (SPPB)
|
0.0 Score on a scale
Standard Deviation 1.1
|
0.6 Score on a scale
Standard Deviation 1.1
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 3 participants did not complete a follow-up CPET assessment due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1).
Peak VO2 (ml/min) non-normalized to weight will be collected using symptom-limited cardiopulmonary exercise testing (CPET). This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Peak Oxygen Utilization (VO2) Non-normalized
|
-77.2 ml/min
Standard Deviation 486.2
|
107.8 ml/min
Standard Deviation 159.4
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 3 participants did not complete a follow-up CPET assessment due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1).
Peak VO2 will be collected using symptom-limited cardiopulmonary exercise testing (CPET). The average sedentary male will achieve a peak VO2 of approximately 35 to 40 mL/kg/min. The average sedentary female will score a VO2 max of between 27 and 30 mL/kg/min. This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Peak Oxygen Utilization (VO2) Normalized to Weight
|
-0.6 ml/kg/min
Standard Deviation 5.0
|
1.1 ml/kg/min
Standard Deviation 1.8
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 3 participants did not complete a follow-up CPET assessment due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1).
VO2 (ml/min) non-normalized at AT will be assessed using symptom-limited CPET. The VO2 at AT for the general population occurs at approximately 50-60% of the peak VO2. This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
VO2 at Anaerobic Threshold (AT) Non-normalized
|
-217.0 ml/min
Standard Deviation 389.5
|
127.8 ml/min
Standard Deviation 304.9
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: 3 participants did not complete a follow-up CPET assessment due to safety concerns/no baseline assessment (n=1), participant withdrawal (n=1), unable to reach/loss to follow-up (n=1).
VO2 (ml/kg/min) at AT will be assessed using symptom-limited CPET. The VO2 at AT for the general population occurs at approximately 50-60% of the peak VO2. This is assessed before and after approx. 14 days of supplementation with Beet-It nitrate beverage vs. placebo. The mean change from baseline to follow-up is used as the outcome measure.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=5 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
VO2 at Anaerobic Threshold (AT) Normalized to Weight
|
-2.0 ml/kg/min
Standard Deviation 4.0
|
1.3 ml/kg/min
Standard Deviation 3.3
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: Baseline and follow-up muscle respirometry data were available for one participant in the Beet-It group, and 5 participants in the placebo group. Follow-up muscle biopsies were not completed due to participant refusal at baseline (n=5), staff availability (n=3), refusal at follow-up (n=1), participant withdrawal (n=1), loss to follow-up/unable to reach to complete assessment (n=1).
To determine the impact of nitrite-rich juice supplementation on skeletal muscle mitochondrial respiration on patients with Long COVID, muscle biopsy of the vastus lateralis will be completed at baseline and following 2 weeks of supplementation. At each time point muscle respiratory capacity will be measured using the Oroboros-2k system. The main outcome will be change in state 3 respiration (maxOXPHOS, pmol/mg/min wet.wt.). Data will be reported as Mean +/- standard deviation.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=1 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=5 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Mitochondrial Respiration
|
9.5 pmol/mg/min wet.wt.
Standard Deviation NA
Both the baseline and follow-up skeletal muscle biopsy were only completed on one participant in this arm.
|
-7.7 pmol/mg/min wet.wt.
Standard Deviation 14.7
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: Baseline and follow-up serology data were available for 3 participants in the Beet-It group and 7 participants in the placebo group. Follow-up blood draws were not completed due to participant refusal at baseline (n=5), participant withdrawal (n=1), loss to follow-up/unable to reach to complete assessment (n=1).
5 ml of blood will be collected from participants and spun down using a centrifuge to separate the plasma from the rest of the blood. Serological sampling is completed at baseline and at final visit. Serum nitrite (µmol/L) and nitrate levels (µmol/L) will be measured at baseline and after the study intervention to evaluate the successful metabolism of nitrate (in beetroot juice) to nitrite.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=3 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=7 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Serum Nitrate
|
26.4 µmol/L
Standard Deviation 12.4
|
4.4 µmol/L
Standard Deviation 5.6
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: Baseline and follow-up serology data were available for 3 participants in the Beet-It group and 7 participants in the placebo group. Follow-up blood draws were not completed due to participant refusal at baseline (n=5), participant withdrawal (n=1), loss to follow-up/unable to reach to complete assessment (n=1).
5 ml of blood will be collected from participants and spun down using a centrifuge to separate the plasma from the rest of the blood. Serological sampling is completed at baseline and at final visit. Serum nitrite (µmol/L) and nitrate levels (µmol/L) will be measured at baseline and after the study intervention to evaluate the successful metabolism of nitrate (in beetroot juice) to nitrite.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=3 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=7 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Serum Nitrite
|
0.4 µmol/L
Standard Deviation 0.6
|
-0.1 µmol/L
Standard Deviation 0.7
|
SECONDARY outcome
Timeframe: Baseline (pre-intervention) to Follow-up (post-intervention); approx. 2 weeksPopulation: Follow-up VR-12 scores were missing for 2 participants due to participant withdrawal (n=1), and loss to follow-up/unable to reach to complete assessment (n=1).
The Veterans RAND-12 (VR-12) is a brief self-administered health survey comprised of 12 items used to measure health related quality of life, estimate disease burden, and evaluate disease-specific benchmarks using two score components: Physical Component Score (PCS) and Mental Component Score (MCS). Summary scores are standardized using a t-score transformation (normalized to US population with mean of 50 and standard deviation of 10). A higher PCS represents better self-reported overall physical function; a higher MCS represents better emotional well-being and fewer mental health limitations.
Outcome measures
| Measure |
Beet-It Nitrate Beverage
n=6 Participants
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 Participants
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Veterans RAND-12 (VR-12)
Physical Component Score
|
3.2 T-Score
Standard Deviation 4.0
|
3.5 T-Score
Standard Deviation 6.2
|
|
Veterans RAND-12 (VR-12)
Mental Component Score
|
-1.2 T-Score
Standard Deviation 5.1
|
-3.9 T-Score
Standard Deviation 7.2
|
Adverse Events
Beet-It Nitrate Beverage
Nitrate-depleted Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Beet-It Nitrate Beverage
n=8 participants at risk
Participant will receive 140 ml per day of Beet-It nitrate beverage for for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK): The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite. The investigators hypothesize that increased nitrite will improve functional metrics and reduce fatigability in Veterans with long COVID as a result of enhanced skeletal muscle mitochondrial respiration. Participant will receive 140 ml per day of Beet-It nitrate beverage for 16 mmol of nitrate/day for 14 days vs the placebo.
|
Nitrate-depleted Placebo
n=9 participants at risk
Participants will receive 210 ml of nitrate-depleted placebo for 14 days. All participants will be encouraged to undergo physical therapy 2-3 times per week based on tolerance for activity and recovery needed after each session. Physical therapy will be standardized to include strength, balance, inspiratory muscle training, and aerobic training.
Participants randomized to this arm will be assessed at baseline and follow-up visits on all outcome measures.
210 ml of nitrate-depleted placebo: Participants randomized to the placebo arm will receive 210 ml of nitrate-depleted beverage (cranberry juice) per day for 14 days.
|
|---|---|---|
|
Gastrointestinal disorders
Grade 1 Bloating
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
Cardiac disorders
Grade 1 Ventricular arrhythmia
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
Vascular disorders
Grade 1 Hypotension
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
Gastrointestinal disorders
Grade 1 Diarrhea
|
25.0%
2/8 • Number of events 2 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
Injury, poisoning and procedural complications
Fall
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
Respiratory, thoracic and mediastinal disorders
Grade 2 Laryngeal stenosis
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
|
General disorders
Flu like symptoms
|
12.5%
1/8 • Number of events 1 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
0.00%
0/9 • From enrollment until the end of follow-up, approximately 14 days
Adverse events were collected during study visits, and periodic check-in phone calls following the baseline and follow-up procedures.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place